Biocon has informed that based on the recommendation of Nomination and Remuneration Committee, the Board at its meeting held on 21 October 2021 has approved an appointment of Eric Vivek Mazumdar as Non-Executive, Non-Independent Director of the Company effective from November 1, 2021, subject to shareholders’ approval at the ensuing Annual General Meeting of the Company. In compliance with Regulation 30 of SEBI Listing Regulations, it enclosed the required disclosure as Annexure A.
The above information is a part of company’s filings submitted to BSE.
